Trade Summary

6 days ago, Schneyer Mark C., serving as EVP, CHIEF FINANCIAL OFFICER at ACADIA PHARMACEUTICALS INC (ACAD), sold 20,141 shares at $29.16 per share, for a total transaction value of $587,242.01. Following this transaction, Schneyer Mark C. now holds 67,828 shares of ACAD.

This sale represents a 22.90% decrease in Schneyer Mark C.'s stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Wednesday, August 5, 2026 and publicly disclosed via SEC Form 4 filing on Friday, August 7, 2026 at 6:00 PM ET, 2 days after the trade was made.

ACADIA PHARMACEUTICALS INC operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.